Molecular Vision 2022; 28:1-10 <>
Received 08 March 2021 | Accepted 20 February 2022 | Published 22 February 2022

Association of ABCA1 (rs2472493) and GAS7 (rs9913911) gene variants with primary open-angle glaucoma in a Brazilian population

Manoel Vinicius Rocha Araki,1 Yuri Carvalho Oiamore Silva,2 Thiago Adalton Rosa Rodrigues,2 Flavia Fialho Bajano,2 Bruno Batista de Souza,2 Fernando Ferreira Costa,3 Vital Paulino Costa,1 Mônica Barbosa de Melo,2 José Paulo Cabral de Vasconcellos1

1Department of Ophthalmology, Faculty of Medical Sciences, University of Campinas – UNICAMP, Campinas – SP, Brazil; 2Laboratory of Human Genetics, Center for Molecular Biology and Genetic Engineering, University of Campinas – UNICAMP, Campinas – SP, Brazil; 3Hematology and Hemotherapy Center, University of Campinas, Campinas - SP, Brazil

Correspondence to: Manoel V. R. Araki, Department of Ophthalmology, Faculty of Medical Sciences, University of Campinas – UNICAMP, Campinas – SP, Brazil; Phone: 55 (19) 3521-7380; email:


Purpose: Glaucoma is the world’s leading cause of irreversible blindness, with primary open-angle glaucoma (POAG) being the most prevalent subtype. In recent years, there have been advances in knowledge about the genetics involved in POAG, but genetic studies in admixed populations, such as Brazilians, are still rare. This study aimed to evaluate the association of single nucleotide variants (SNV) of the ABCA1 (rs2472493) and GAS7 (rs9913911) genes with POAG in a sample of the Brazilian population. Furthermore, the study aimed to evaluate the relationship between these SNVs and the need for surgical intervention in glaucoma control.

Methods: A cross-sectional association study with 1,009 subjects (505 patients with POAG and 504 controls) was performed. Participants underwent a comprehensive ocular examination, including the need for surgical procedures for intraocular pressure control. Genotyping of SNVs was performed using the TaqMan genotyping assay.

Results: SNV rs9913911 of GAS7 was found to be associated with POAG in the presence of the risk allele A (p = 0.0004) and the AA genotype (p = 0.002). There was no association between SNV rs2472493 of ABCA1 for either the allele risk or genotypes. However, the combination of these variants showed an additive effect on the risk for POAG: ABCA1(GG) + GAS7(AA; p = 0.02), ABCA1(GG) + GAS7(AG; p = 0.003), and ABCA1(AG) + GAS7(AG; p = 0.004). Also, POAG patients carrying the AA genotype of the GAS7 gene required antiglaucomatous surgery more frequently than those without the AA genotype (p = 0.01).

Conclusions: In a Brazilian population sample, there was an association identified between SNV rs9913911 (GAS7) and the risk of POAG, and an additive effect was found when GAS7 was combined with SNV rs2472493 (ABCA1). There was an association between SNV rs9913911 (GAS7) and the risk for antiglaucomatous surgery.


Glaucoma is the world’s leading cause of irreversible blindness [1,2]. About 76 million people are affected by glaucoma [2], with approximately 11.2 million progressing to bilateral blindness [1]. There are several types of glaucoma each with distinct characteristics [3], but primary open-angle glaucoma (POAG) is the most prevalent and is estimated to account for 74% of all cases [4]. Latin America has the second-highest prevalence of POAG, second only to Africa [2].

POAG is a progressive multifactorial neurodegenerative disease that affects the optic nerve and leads to the loss of retinal ganglion cells (RGCs) and their axons (nerve fibers). This degeneration is characterized by structural changes in the optic nerve head (ONH) and corresponding visual field defects [1,3,5]. Treatment is performed by reducing intraocular pressure (IOP), which is the main risk factor in determining glaucomatous damage and the only parameter that can directly act as treatment [6,7]. In some patients, IOP control is not achieved with clinical treatment; therefore, antiglaucomatous surgery is indicated.

A strong genetic component is involved in the development of POAG. Several studies have identified susceptibility loci for POAG. The first studies, performed by genetic linkage, identified genes with a monogenic pattern of inheritance, such as MYOC, OPTN, and CYP1B1 [810]. Individuals with this form of inheritance usually develop the disease at an early age (<40 years) [1114]. However, disease-causing variants in these genes are relatively rare in the population, accounting for only 5%–10% of all cases of POAG [12,15,16].

Most cases of POAG occur after the age of 40 and have a complex pattern of inheritance resulting from the interaction of several genes and environmental factors [13,1721]. In this form of polygenic inheritance, each single nucleotide variant (SNV) of different genes represents a minor effect on disease pathogenesis, and when combined, they significantly affect the clinical phenotype [1113,17,18]. In recent years, more than 120 SNVs linked to POAG have been identified through genome-wide association studies (GWAS) [22,23].

Most of these studies were conducted in Asian or Caucasian populations. Depending on the population being assessed, the same SNV may or may not have an association with POAG. Therefore, replication studies must be performed to confirm the effects of these SNVs in other regions or with other ethnicities. Among the SNVs robustly identified in multiethnic studies, the rs2472493 (ABCA1) and rs9913911 (GAS7) variants were significantly associated with POAG [22,24]. However, no individuals from South America participated in that study. Therefore, these two variants were selected to increase the odds of finding an association in our Brazilian admixed population because they could be more representative across different ethnicities. Even with the high prevalence of POAG in this region, genetic research has been scarce. To date, there has been no study of the relationship between SNVs in ABCA1 and GAS7 genes and POAG in Brazil. These aspects are relevant to this area of research considering the highly miscegenational Brazilian population.

The main objective of this study was to evaluate the association of the SNVs of ABCA1 (rs2472493) and GAS7 (rs9913911) to the risk of developing POAG in a sample of the Brazilian population. Moreover, we evaluated a) the combination of these SNVs with the risk of POAG and b) the relationship of these SNVs to the need for surgical intervention.


A cross-sectional association case-control study was conducted at the Center for Molecular Biology and Genetic Engineering (CBMEG) and Department of Ophthalmology, Clinical Hospital, University of Campinas (UNICAMP), Campinas, São Paulo and the Regional Hospital of Divinolândia, Divinolândia, São Paulo. The study was approved by the Ethics and Research Committee of the Faculty of Medical Sciences, University of Campinas (UNICAMP). The principles of the Declaration of Helsinki were respected, and written informed consent was obtained from all participants.


Individuals over 40 years of age participated in the study. Participants underwent ophthalmologic examinations, and those who met the selection criteria were classified into either the case group (POAG) or the control group.

The case group was composed of patients with POAG as defined by the following criteria: a) open angle at gonioscopy (according to Foster criteria) [25]; b) IOP >21 mmHg; c) ONH with at least two criteria (cupping >0.7, cupping asymmetry >0.2, thinning of the neuroretinal rhyme, hemorrhage or notch in the ONH); or d) typical visual field defects according to Anderson’s criteria [26] (Humphrey, SITA-standart 24–2 or 30–2). Surgical procedures were indicated when IOP was uncontrolled with risk or evidence of glaucoma progression.

The control group consisted of individuals over 40 years of age who had been seen at the previously mentioned ophthalmology outpatient clinics. The selected participants had ophthalmologic examinations, with results that included open angle at gonioscopy, IOP <21 mmHg, ONH cup <0.5, and no family history of glaucoma or blindness of unknown origin.

Participants who had any of the following exclusion criteria were removed from the study: secondary glaucomas, developmental glaucomas, high myopes (> −6.0 ED), fundoscopic changes compatible with age-related macular degeneration, severe diabetic retinopathies, optic neuropathies, neurodegenerative diseases, or ocular or systemic diseases that could affect a visual field examination of the optic nerve.

Genetic evaluation

All participants (cases and controls) had 5–10 ml of peripheral blood drawn into a sterile vial containing ethylene diamine tetraacetic acid (EDTA). Genomic DNA was extracted using the phenol/chloroform method.

A polymerase chain reaction was performed to amplify the region containing the studied SNVs. The genotyping of the SNVs rs9913911 of the GAS7 gene and rs2472493 of the ABCA1 gene for the identification of risk alleles A (GAS7) and G (ABCA1) was performed with a TaqMan assay according to the standardization protocol provided by the manufacturer (SNP Genotyping Assays TaqMan, Thermo Fisher, Waltham, MA). The genotyping results were confirmed in 10% of the samples using Sanger sequencing.

Statistical analysis

All statistical analyses were performed using R software (R Core Team, 2014). All genotypes of the case and control groups were evaluated for Hardy–Weinberg equilibrium (HWE) using the chi-square goodness-of-fit test. Analyses of gender and age were performed by Fischer’s exact test and the Mann–Whitney nonparametric test, respectively. To investigate the association of the variants with POAG, a logistic regression model (stepwise) was used (Stats Package of R; R Core Team, 2014). To analyze the association between the need for antiglaucomatous surgery and the variants, the chi-square test was used. The Kruskal–Wallis test was performed to analyze the association of the number of antiglaucomatous surgeries with the variants. Statistical significance was p <0.05.


The total sample size was 1,009 participants. The case group consisted of 505 subjects, 51.3% male, and the control group consisted of 504 subjects, 57.7% female (p = 0.004). The mean ages were 68.1 ± 11.8 for the case group and 66.7 ± 10.1 for the control group (p = 0.047; Table 1). Due to the differences observed in sex and age between the groups, the analyses were adjusted for these variables. Table 2 depicts the genotypic and allelic frequencies of each variant and the HWE p value. All cases and controls were in HWE (p >0.05) for the two variants studied.

Multivariate logistic regression analysis, adjusted for sex and age, was performed to analyze the association of the studied variants with the presence of POAG (Table 3). The presence of the risk allele A of the GAS7 variant rs9913911 was found to have a significant association with POAG (p = 0.0004, OR 1.41), as well as with the AA genotype (p = 0.002, OR 1.96). For the ABCA1 variant rs2472493, there were no significant associations with the alleles and genotypes. However, when evaluating the combination of these two variants, an additive effect was observed in the risk for POAG with the following haplotypes: ABCA1(GG) + GAS7(AA; p = 0.02), ABCA1(GG) + GAS7(AG; p = 0.003), and ABCA1(AG) + GAS7(AG; p = 0.004) (Table 4). However, in terms of age and sex, no significant associations were observed among these haplotypes.

An analysis was conducted to identify associations between the studied risk variants and antiglaucomatous surgery (Table 5). The ABCA1 genotypes showed no association with the need for antiglaucomatous surgery, but for the GAS7 gene, a higher number of individuals carrying the AA genotype needed antiglaucomatous surgery (p = 0.01, OR 1.90). There was no relationship between the number of antiglaucomatous surgeries and the investigated variants (Table 6).


Genetic studies related to POAG have only rarely been conducted among South American populations, including the Brazilian population, which represents approximately 49% of individuals from this region (United Nations 2020 Demographic Yearbook. 71st Issue. New York, United Nations 2021). To our knowledge, this was the first study investigating the SNVs of ABCA1 (rs2472493) and GAS7 (rs9913911) in a sample of the Brazilian population. This was a case-control study with 1,009 participants and consisted of the replication of GAS7 and ABCA1 variants that were previously associated with POAG. The results are important, considering that the Brazilian population is highly admixed and ethnically heterogeneous [2830]. Furthermore, the analysis of these variants contributes to the creation of a genetic panel of POAG risk for Brazilians.

In this study, the frequencies of the GAS7rs9913911 A allele and the ABCA1rs2472493 G allele were 0.684 and 0.411, respectively. These frequencies are in agreement with the three largest multiethnic genomic data sets of these SNVs in the human species (TopMed, gnomAD, 1000Genome) rs9913911, rs2472493 [31,32] (Supplementary Table 1). These data indicate that due to its miscegenation, the Brazilian population could be a valuable resource for studies aimed at using admixture as a tool for mapping complex traits in humans.

SNV rs9913911 (GAS7) showed a significant association with POAG. Individuals carrying the A risk allele were 41% more likely to have glaucoma, and in the presence of the AA genotype, the figure was 96%, suggesting that each copy of the A allele confers an increased risk of POAG. This result is consistent with previous studies conducted in other populations. A study by Hysi and collaborators [31] examining Caucasian individuals from Australia, New Zealand, Iceland, and the USA was the first to identify the association between GAS7rs9913911 and POAG (p = 2.98E-13). This finding was later replicated in other studies of Caucasian (p = 2.13E-21) [32] and Japanese (p = 3.32E-04) populations [33]. A multiethnic study revealed an association between the GAS7 variant and POAG in Caucasians (p = 6.9E-17) but not in Asians, Hispanics, and African Americans; there were no participants from South America [24]. Recently, a multiethnic meta-analysis also detected this association in Caucasians and Asians (p = 5.90E-33 and p = 1.02E-06, respectively), but not in African descendants [22] (Supplementary Table 2).

Regarding the rs2472493 variant (ABCA1), no significant associations of the G risk allele or GG genotype and POAG were observed, in contrast to previous studies performed in Caucasians from the USA, Europe, and Oceania [24,31,32,34] or in the Japanese population [35]. Other studies conducted with different ethnicities also found no association between rs2472493 and POAG. One was a study by Alkhatib et al. [36] with a sample of Jordanian Arabs in which there was no association of this variant with POAG (p = 0.69 for allele and p = 0.71 for genotype). Bonnemaijer and colleagues [37] conducted a multicenter study with a large number of African and African American participants, and their results also showed no significant association (p = 0.093). A multiethnic GWAS performed by Choquet and collaborators [24] reported no association of this SNV with POAG in Hispanics, Asians, or African Americans as well (p = 0.046, p = 0.90, and p = 0.018, respectively). These divergent results in different populations may be due to differences in the ancestry architecture, as well as different genetic etiologies in the development of glaucoma (Supplementary Table 3).

The effect of the combination of the risk variants of the ABCA1 and GAS7 genes was analyzed. This haplotype showed an additive effect on the risk of developing POAG. To date, no studies have analyzed the combination of these variants alone. The GAS7 gene is mainly related to aqueous humor homeostasis, and variants in this gene have also been associated with increased IOP [31,3841]. The ABCA1 gene has also been identified in GWAS involving endophenotypes, such as IOP [31]. However, the ABCA1 gene is associated with age-related neuroinflammatory and neurodegenerative processes, which may increase susceptibility to loss of RGCs, facilitating glaucomatous damage [4246]. One of the possible mechanisms is TBK1 activation, which leads to ABCA1 ubiquitination. Its degradation reduces ANXA secretion, facilitating retinal inflammation and RGC apoptosis [47]. Furthermore, the GAS7 and ABCA1 genes may interact through the ARHGEF12 gene (using ingenuity pathway analysis) and influence the risk of glaucoma by increasing IOP [48]. Both the ABCA1 and GAS7 genes are expressed in ocular tissues, including sclera, cornea, optic nerve, trabecular meshwork, and retina [31]. The SNV rs2472493, located upstream of ABCA1 (Genevar database), is associated with ABCA1 transcript levels in lymphoblastoid cell lines and may change the sequence of motifs for proteins such as FOXJ2 and SIX5. This SNV is also in high linkage disequilibrium with an SNV near ABCA1 (rs2472494) that alters the regulatory motif for binding of the PAX6 gene, involved in eye development. Therefore, these characteristics may suggest regulatory roles for rs2472493 and rs2472494 (near ABCA1) [34] in gene expression. According to the Ensembl Genome Browser, the SNV 9,913,911 (GAS7 gene) is an intron variant located in a regulatory region, but to our knowledge, no data on how this variant might change gene expression have been reported. Therefore, when evaluating the combination of these risk variants, the increased risk of POAG may be due to the different mechanisms involved in glaucoma pathophysiology (trabecular meshwork and ONH) compacted with the hypothesis of the complex inheritance pattern of this ocular disorder. Thus, in addition to functional studies, further studies in other populations are needed to replicate these findings and to ratify this hypothesis.

The current study also evaluated whether these specific variants were associated with the need for antiglaucomatous surgery. The need for surgery may be indicative of a more severe evolution of glaucoma; however, it is important to consider that several factors may influence the indication of a surgical procedure, such as glaucoma stage and treatment compliance, among others. These are difficult factors to control for in a study with this design, making a prospective longitudinal controlled study more suitable. In the current study, patients with POAG and the AA genotype for GAS7 (rs9913911) had a 90% greater chance of requiring surgery for glaucoma treatment, which may indicate a more aggressive glaucoma evolution. There was no significant association regarding the number of surgeries. To date, no studies have performed this analysis.

The present study had a sample size limitation, which probably made it difficult to detect an association between rs2472493 (ABCA1) and POAG. This result may also indicate that the effect conferred by this variant was low in this population, which would explain the need for such a large sample size to detect an association. However, for rs9913911 (GAS7), it was possible to replicate previously published results and reinforce the importance of this variant with POAG. The post hoc analysis showed that the sample had a power of 80.9% to detect differences regarding the risk allele A compared to the wild-type allele G in the GAS7 gene. Regarding the G risk allele in the ABCA1 gene, a sample of 17,200 individuals would be required to obtain a sample power of 80% with a type I error of 5%. Given its transversal design, this study was not able to robustly address the evaluation of a combination of both alleles with regard to age of diagnosis and IOP due to a lack of information about adherence to treatment and late diagnosis of glaucoma.

The strength of this study was the careful diagnoses of the cases, performed by specialists. The controls were subjected to strict criteria, and only participants over 40 years old were included to increase the diagnostic certainty of the non-disease state. Another positive aspect was that the replication of these variants in Brazil was performed in the state of São Paulo, which is characterized by a highly admixed population [49], a factor that differentiates this study from most others that were conducted in other countries [49]. Admixed populations, such as those in Brazil, are underrepresented in genomic banks, which contain data mostly from Caucasian populations [49]. The Brazilian population is highly heterogeneous and resulted from migration events over five centuries that were accompanied by the intensive admixing of three main ancestral roots: Amerindians (the native population), Europeans, and Africans (the two main sources of migration) [29]. Brazil is a country of continental dimensions, and its genetic composition varies from region to region [29]. However, it has been demonstrated that urban populations tend to be genetically equivalent [50]. For autosomal markers, the proportion of European ancestry has been estimated at 60%–79%, with African ancestry at 10%–29% [50] and Amerindian ancestry at 7%–18% [50]. The lack of diversity in international gene banks may limit access for people of non-Caucasian ancestry to the benefits of precision medicine and more accurate testing, potentially increasing health disparities [51]. These reasons justify the need for further studies to better understand the role of genetic variants in susceptibility to POAG in the Brazilian population.


In conclusion, this study has shown that in this sample of the Brazilian population, the rs9913911 variant of the GAS7 gene is significantly associated with POAG in the presence of the A allele and the AA genotype. There was no significant association between the rs2472493 variant of the ABCA1 gene and POAG; however, when in combination with the GAS7 risk allele, there was an additive risk effect for POAG. Additionally, there was a significant relationship between the need for antiglaucomatous surgery and the presence of the AA genotype of the rs9913911 variant of the GAS7 gene. These findings provide further insight into the genetic profile associated with the pathogenesis of glaucoma in our population.

Appendix 1. Frequencies of risk alleles of the GAS7 (rs9913911) and ABCA1 (rs2472493) variants.

Appendix 2. Association of the GAS7 (rs9913911) variant with POAG.

Appendix 3. Association of the ABCA1 (rs2472493) variant with POAG.


Funding sources: This project was supported by FAPESP (grants 2002/11575-0; 2010/18353-9; 2018/20628-8) and FAEPEX (grant 2182/20).


  1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90:262-7. [PMID: 16488940]
  2. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014; 121:2081-90. [PMID: 24974815]
  3. Kwon YH, Fingert JH, Kuehn MH, Alward WLM. Primary open-angle glaucoma. N Engl J Med. 2009; 360:1113-24. [PMID: 19279343]
  4. Cedrone C, Mancino R, Cerulli A, Cesareo M, Nucci C. Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects. Prog Brain Res. 2008; 173:3-14. [PMID: 18929097]
  5. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma. JAMA. 2014; 311:1901-11. [PMID: 24825645]
  6. The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000; 130:429-40. [PMID: 11024415]
  7. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120:1268-79.
  8. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC. Identification of a gene that causes primary open-angle glaucoma. Science. 1997; 275:668-70. [PMID: 9005853]
  9. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Héon E, Krupin T, Ritch R, Kreutzer D, Crick RP, Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002; 295:1077-9. [PMID: 11834836]
  10. Stoilov I, Akarsu AN, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A Locus on chromosome 2p21. Hum Mol Genet. 1997; 6:641-7. [PMID: 9097971]
  11. Wiggs JL, Pasquale LR. Genetics of glaucoma. Hum Mol Genet. 2017; 26:21-7. [PMID: 28505344]
  12. Trivli A, Zervou MI, Goulielmos GN, Spandidos DA, Detorakis ET. Primary open-angle glaucoma genetics: the common variants and their clinical associations Mol Med Rep. 2020; 22:1103-10.
    [PMID: 32626970]
  13. Qassim A, Souzeau E, Siggs OM, Hassall MM, Han X, Griffiths HL, Frost NA, Vallabh NA, Kirwan JF, Menon G, Cree AJ, Galanopoulos A, Agar A, Healey PR, Graham SL, Landers J, Casson RJ, Gharahkhani P, Willoughby CE, Hewitt AW, Lotery AJ, MacGregor S, Craig JE. An intraocular pressure polygenic risk score stratifies multiple primary open-angle glaucoma parameters including treatment intensity. Ophthalmology. 2020; 127:901-7. [PMID: 32081492]
  14. Charlesworth J, Kramer PL, Dyer T, Diego V, Samples JR, Craig JE, Mackey DA, Hewitt AW, Blangero J, Wirtz MK. The path to open-angle glaucoma gene discovery: endophenotypic status of intraocular pressure, cup-to-disc ratio, and central corneal thickness. Invest Ophthalmol Vis Sci. 2010; 51:3509-14. [PMID: 20237253]
  15. Fingert JH. Primary open-angle glaucoma genes. Eye (Lond). 2011; 25:587-95. [PMID: 21562585]
  16. Sakurada Y, Mabuchi F. Advances in glaucoma genetics. Prog Brain Res. 2015; 220:107-26. [PMID: 26497787]
  17. Brazilian Council of Ophthalmology (CBO). Série Oftalmologia Brasileira (Glaucoma). 3rd ed. Rio de Janeiro: Cultura Médica: Guanabara Koogan, 2013.
  18. Asefa NG, Neustaeter A, Jansonius NM, Snieder H. Heritability of glaucoma and glaucoma-related endophenotypes: a systematic review and meta-analysis protocol. Surv Ophthalmol. 2019; 64:835-51. [PMID: 31229521]
  19. Fan BJ, Leung YF, Wang N, Lam SC, Liu Y, Tam OS, Pang CP. Genetic and environmental risk factors for primary open-angle glaucoma. Chin Med J (Engl). 2004; 117:706-10. [PMID: 15161538]
  20. Wiggs JL, Damji KF, Haines JL, Pericak-Vance MA, Allingham RR. The distinction between juvenile and adult-onset primary open-angle glaucoma. Am J Hum Genet. 1996; 58:243-4. [PMID: 8554064]
  21. Kang JH, Wiggs JL, Rosner BA, Hankinson SE, Abdrabou W, Fan BJ, Haines J, Pasquale LR. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use. Invest Ophthalmol Vis Sci. 2010; 51:971-9. [PMID: 19815736]
  22. Gharahkhani P, Jorgenson E, Hysi P, Khawaja AP, Pendergrass S, Han X, Ong JS, Hewitt AW, Segrè AV, Rouhana JM, Hamel AR, Igo RP, , Jr Choquet H, Qassim A, Josyula NS, Cooke Bailey JN, Bonnemaijer PWM, Iglesias A, Siggs OM, Young TL, Vitart V, Thiadens AAHJ, Karjalainen J, Uebe S, Melles RB, Nair KS, Luben R, Simcoe M, Amersinghe N, Cree AJ, Hohn R, Poplawski A, Chen LJ, Rong SS, Aung T, Vithana EN, NEIGHBORHOOD consortium. ANZRAG consortium; Biobank Japan project; FinnGen study; UK Biobank Eye and Vision Consortium; GIGA study group; 23 and Me Research Team, Tamiya G, Shiga Y, Yamamoto M, Nakazawa T, Currant H, Birney E, Wang X, Auton A, Lupton MK, Martin NG, Ashaye A, Olawoye O, Williams SE, Akafo S, Ramsay M, Hashimoto K, Kamatani Y, Akiyama M, Momozawa Y, Foster PJ, Khaw PT, Morgan JE, Strouthidis NG, Kraft P, Kang JH, Pang CP, Pasutto F, Mitchell P, Lotery AJ, Palotie A, van Duijn C, Haines JL, Hammond C, Pasquale LR, Klaver CCW, Hauser M, Khor CC, Mackey DA, Kubo M, Cheng CY, Craig JE, MacGregor S, Wiggs JL. Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. Nat Commun. 2021; 12:1258 [PMID: 33627673]
  23. Khawaja AP, Cooke Bailey JN, Wareham NJ, Scott RA, Simcoe M, Igo Jr RP, Song YE, Wojciechowski R, Cheng CY, Khaw PT, Pasquale LR, Haines JL, Foster PJ, Wiggs JL, Hammond CJ, Hysi PG, UK Biobank Eye and Vision Consortium, Neighborhood Consortium. Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma. Nat Genet. 2018; 50:778-82. [PMID: 29785010]
  24. Choquet H, Paylakhi S, Kneeland SC, Thai KK, Hoffmann TJ, Yin J, Kvale MN, Banda Y, Tolman NG, Williams PA, Schaefer C, Melles RB, Risch N, John SWM, Nair KS, Jorgenson E. A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci. Nat Commun. 2018; 9:2278 [PMID: 29891935]
  25. Foster PJ, Devereux JG, Alsbirk PH, Lee PS, Uranchimeg D, Machin D, Johnson GJ, Baasanhu J. Detection of Gonioscopically occludable angles and primary angle-closure glaucoma by estimation of limbal chamber depth in asians: modified grading scheme. Br J Ophthalmol. 2000; 84:186-92.
  26. Anderson DR. Automated static perimetry. CV Mosby: St. Louis, 1992, p. 76–161.
  27. Naslavsky MS, Yamamoto GL, de Almeida TF, Ezquina SAM, Sunaga DY, Pho N, Bozoklian D, Sandberg TOM, Brito LA, Lazar M, Bernardo DV, Amaro E, , Jr Duarte YAO, Lebrão ML, Passos-Bueno MR, Zatz M. Exomic variants of an elderly cohort of Brazilians in the ABraOM database. Hum Mutat. 2017; 38:751-63.
  28. Sans M. Admixture studies in Latin America: From the 20th to the 21st century. Hum Biol. 2000; 72:155-77. [PMID: 10721616]
  29. Giolo SR, Soler JM, Greenway SC, Almeida MA, de Andrade M, Seidman JG, Seidman CE, Krieger JE, Pereira AC. Brazilian urban population genetic structure reveals a high degree of admixture. Eur J Hum Genet. 2012; 20:111-6. [PMID: 21863058]
  30. Melo MB, Ananina G, Bezerra MA. Araújo, Cruz PRS, Simioni GSL, Costa VP. A high degree of admixture in an urban Brazilian population. In: American Society of Human Genetics 64th Annual Meeting, 2014, San Diego. American Society of Human Genetics 64th Annual Meeting Poster Abstracts, 2014.
  31. Hysi PG, Cheng CY, Springelkamp H, Macgregor S, Bailey JNC, Wojciechowski R, Vitart V, Nag A, Hewitt AW, Höhn R, Venturini C, Mirshahi A, Ramdas WD, Thorleifsson G, Vithana E, Khor CC, Stefansson AB, Liao J, Haines JL, Amin N, Wang YX, Wild PS, Ozel AB, Li JZ, Fleck BW, Zeller T, Staffieri SE, Teo YY, Cuellar-Partida G, Luo X, Allingham RR, Richards JE, Senft A, Karssen LC, Zheng Y, Bellenguez C, Xu L, Iglesias AI, Wilson JF, Kang JH, van Leeuwen EM, Jonsson V, Thorsteinsdottir U, Despriet DDG, Ennis S, Moroi SE, Martin NG, Jansonius NM, Yazar S, Tai ES, Amouyel P, Kirwan J, van Koolwijk LME, Hauser MA, Jonasson F, Leo P, Loomis SJ, Fogarty R, Rivadeneira F, Kearns L, Lackner KJ, de Jong PTVM, Simpson CL, Pennell CE, Oostra BA, Uitterlinden AG, Saw SM, Lotery AJ, Bailey-Wilson JE, Hofman A, Vingerling JR, Maubaret C, Pfeiffer N, Wolfs RCW, Lemij HG, Young TL, Pasquale LR, Delcourt C, Spector TD, Klaver CCW, Small KS, Burdon KP, Stefansson K, Wong TY, BMES GWAS Group. NEIGHBORHOOD Consortium; Wellcome Trust Case Control Consortium 2, Viswanathan A, Mackey DA, Craig JE, Wiggs JL, van Duijn CM, Hammond CJ, Aung T. Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat Genet. 2014; 46:1126-30. [PMID: 25173106]
  32. MacGregor S, Ong JS, An J, Han X, Zhou T, Siggs OM, Law MH, Souzeau E, Sharma S, Lynn DJ, Beesley J, Sheldrick B, Mills RA, Landers J, Ruddle JB, Graham SL, Healey PR, White AJR, Casson RJ, Best S, Grigg JR, Goldberg I, Powell JE, Whiteman DC, Radford-Smith GL, Martin NG, Montgomery GW, Burdon KP, Mackey DA, Gharahkhani P, Craig JE, Hewitt AW. Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma. Nat Genet. 2018; 50:1067-71. [PMID: 30054594]
  33. Shiga Y, Nishiguchi KM, Kawai Y, Kojima K, Sato K, Fujita K, Takahashi M, Omodaka K, Araie M, Kashiwagi K, Aihara M, Iwata T, Mabuchi F, Takamoto M, Ozaki M, Kawase K, Fuse N, Yamamoto M, Yasuda J, Nagasaki M, Nakazawa T, Japan Glaucoma Society Omics Group (JGS-OG). Genetic Analysis of Japanese Primary open-angle glaucoma patients and clinical characterization of risk alleles near CDKN2B–AS1, SIX6, and GAS7. PLoS One. 2017; 12:e0186678 [PMID: 29261660]
  34. Gharahkhani P, Burdon KP, Fogarty R, Sharma S, Hewitt AW, Martin S, Law MH, Cremin K, Bailey JNC, Loomis SJ, Pasquale LR, Haines JL, Hauser MA, Viswanathan AC, McGuffin P, Topouzis F, Foster PJ, Graham SL, Casson RJ, Chehade M, White AJ, Zhou T, Souzeau E, Landers J, Fitzgerald JT, Klebe S, Ruddle JB, Goldberg I, Healey PR. Wellcome Trust Case Control Consortium 2, NEIGHBORHOOD Consortium, Mills RA, Wang JJ, Montgomery GW, Martin NG, Radford-Smith G, Whiteman DC, Brown MA, Wiggs JL, Mackey DA, Mitchell P, MacGregor S, Craig JE. Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. Nat Genet. 2014; 46:1120-5. [PMID: 25173105]
  35. Shiga Y, Akiyama M, Nishiguchi KM, Sato K, Shimozawa N, Takahashi A, Momozawa Y, Hirata M, Matsuda K, Yamaji T, Iwasaki M, Tsugane S, Oze I, Mikami H, Naito M, Wakai K, Yoshikawa M, Miyake M, Yamashiro K. Japan Glaucoma Society Omics Group (JGS-OG), Kashiwagi K, Iwata T, Mabuchi F, Takamoto M, Ozaki M, Kawase K, Aihara M, Araie M, Yamamoto T, Kiuchi Y, Nakamura M, Ikeda Y, Sonoda KH, Ishibashi T, Nitta K, Iwase A, Shirato S, Oka Y, Satoh M, Sasaki M, Fuse N, Suzuki Y, Cheng CY, Khor CC, Baskaran M, Perera S, Aung T, Vithana EN, Cooke Bailey JN, Kang JH, Pasquale LR, Haines JL; NEIGHBORHOOD Consortium, Wiggs JL, Burdon KP, Gharahkhani P, Hewitt AW, Mackey DA, MacGregor S, Craig JE, Allingham RR, Hauser M, Ashaye A, Budenz DL, Akafo S, Williams SEI, Kamatani Y, Nakazawa T, Kubo M. Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma. Hum Mol Genet. 2018; 15:1486-96.
  36. Alkhatib R, Abudhaim N. AL-Eitan L, Abdo N, Alqudah A, Aman H. Genetic analysis of ABCA1 gene of primary glaucoma in Jordanian Arab population. Appl Clin Genet. 2019; 12:181-9. [PMID: 31632126]
  37. Bonnemaijer PW, Iglesias A, Nadkarni GN, Sanyiwa AJ, Hassan HG, Cook C, GIGA Study Group. Simcoe M, Taylor KD, Schurmann C, Belbin GM, Kenny EE, Bottinger EP, van de Laar S, Wiliams SEI, Akafo SK, Ashaye AO, Zangwill LM, Girkin CA, Ng MCY, Rotter JI, Weinreb RN, Li Z, Allingham RR; Eyes of Africa Genetics Consortium, Nag A, Hysi PG, Meester-Smoor MA, Wiggs JL; NEIGHBORHOOD Consortium, Hauser MA, Hammond CJ, Lemij HG, Loos RJF, van Duijn CM, Thiadens AAHJ, Klaver CCW. Genome-wide association study of primary open-angle glaucoma in continental and admixed African populations. Hum Genet. 2018; 137:847-62. [PMID: 30317457]
  38. Liton PB, Luna C, Challa P, Epstein DL, Gonzalez P. Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open-angle glaucoma tissue. Mol Vis. 2006; 12:774-90. [PMID: 16862071]
  39. van Koolwijk LM, Ramdas WD, Ikram MK, Jansonius NM, Pasutto F, Hysi PG, Macgregor S, Janssen SF, Hewitt AW, Viswanathan AC, ten Brink JB, Hosseini SM, Amin N, Despriet DD, Willemse-Assink JJ, Kramer R, Rivadeneira F, Struchalin M, Aulchenko YS, Weisschuh N, Zenkel M, Mardin CY, Gramer E, Welge-Lüssen U, Montgomery GW, Carbonaro F, Young TL, DCCT/EDIC Research Group. Bellenguez C, McGuffin P, Foster PJ, Topouzis F, Mitchell P, Wang JJ, Wong TY, Czudowska MA, Hofman A, Uitterlinden AG, Wolfs RC, de Jong PT, Oostra BA, Paterson AD; Wellcome Trust Case Control Consortium 2, Mackey DA, Bergen AA, Reis A, Hammond CJ, Vingerling JR, Lemij HG, Klaver CC, van Duijn CM. Common genetic determinants of intraocular pressure and primary open-angle glaucoma. PLoS Genet. 2012; 8:e1002611 [PMID: 22570627]
  40. Gotoh A, Hidaka M, Hirose K, Uchida T. GAS7b (growth arrest-specific protein 7b) regulates neuronal cell morphology by enhancing microtubule and actin filament assembly. J Biol Chem. 2013; 288:34699-706. [PMID: 24151073]
  41. Ozel AB, Moroi SE, Reed DM, Nika M, Schmidt CM, Akbari S, Scott K, Rozsa F, Pawar H, Musch DC, Lichter PR, Gaasterland D, Branham K, Gilbert J, Garnai SJ, Chen W, Othman M, Heckenlively J, Swaroop A, Abecasis G, Friedman DS, Zack D, Ashley-Koch A, Ulmer M, Kang JH, NEIGHBOR Consortium. Liu Y, Yaspan BL, Haines J, Allingham RR, Hauser MA, Pasquale L, Wiggs J, Richards JE, Li JZ. Genome-wide association study and meta-analysis of intraocular pressure. Hum Genet. 2014; 133:41-57. [PMID: 24002674]
  42. Akiyama TE, Sakai S, Lambert G, Nicol CJ, Matsusue K, Pimprale S, Lee YH, Ricote M, Glass CK, Brewer HB, , Jr Gonzalez FJ. Conditional disruption of the peroxisome proliferator-activated receptor-gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol. 2002; 22:2607-19. [PMID: 11909955]
  43. van Eck M, Bos IS, Kaminski WE, Orso E, Rothe G, Twisk J, Bottcher A, Van Amersfoort ES, Christiansen-Weber TA, Fung-Leung WP, Van Berkel TJ, Schmitz G. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci USA. 2002; 99:6298-303. [PMID: 11972062]
  44. Efferth T. Adenosine triphosphate-binding cassette transporter genes in aging and age-related diseases. Ageing Res Rev. 2003; 2:11-24. [PMID: 12437993]
  45. Karasinska JM, de Hann W, Franciosi S, Ruddle P, Fan J, Kruit JK, Stukas S, Lütjohann D, Gutmann DH, Wellington CL, Hayden MR. ABCA1 influences neuroinflammation and neuronal death. Neurobiol Dis. 2013; 54:445-55. [PMID: 23376685]
  46. Howell GR, Macalinao DG, Sousa GL, Walden M, Soto I, Kneeland SC, Barbay JM, King BL, Marchant JK, Hibbs M, Stevens B, Barres BA, Clark AF, Libby RT, John SW. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011; 121:1429-44.
  47. Li L, Xu L, Chen W, Li X, Xia Q, Zheng L, Duan Q, Zhang H, Zhao Y. Reduced Annexin A1 Secretion by GAS7 Causes Retinal Inflammation and Ganglion Cell Apoptosis in a Murine Glaucoma Model. Front Cell Neurosci. 2018; 12:347 [PMID: 30364320]
  48. Springelkamp H, Iglesias AI, Cuellar-Partida G, Amin N, Burdon KP, van Leeuwen EM, Gharahkhani P, Mishra A, van der Lee SJ, Hewitt AW, Rivadeneira F, Viswanathan AC, Wolfs RCW, Martin NG, Ramdas WD, van Koolwijk LM, Pennell CE, Vingerling JR, Mountain JE, Uitterlinden AG, Hofman A, Mitchell P, Lemij HG, Wang JJ, Klaver CCW, Mackey DA, Craig JE, van Duijn CM, MacGregor S. ARHGEF12 influences the risk of glaucoma by increasing intraocular pressure. Hum Mol Genet. 2015; 24:2689-99. [PMID: 25637523]
  49. Naslavsky MS, Yamamoto GL, de Almeida TF, Ezquina SAM, Sunaga DY, Pho N, Bozoklian D, Sandberg TOM, Brito LA, Lazar M, Bernardo DV, Amaro E, , Jr Duarte YAO, Lebrão ML, Passos-Bueno MR, Zatz M. Whole-genome sequencing of 1,171 elderly admixed individuals from the largest Latin American metropolis (São Paulo, Brazil). bioRxiv. 2020; 38:753-61.
  50. Pena SD, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy Fde S, Kohlrausch F, Magno LA, Montenegro RC, Moraes MO, de Moraes ME, de Moraes MR, Ojopi EB, Perini JA, Racciopi C, Ribeiro-Dos-Santos AK, Rios-Santos F, Romano-Silva MA, Sortica VA, Suarez-Kurtz G. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One. 2011; 6:e17063 [PMID: 21359226]
  51. Kehdy FS, Gouveia MH, Machado M, Magalhães WC, Horimoto AR, Horta BL, Moreira RG, Leal TP, Scliar MO, Soares-Souza GB, Rodrigues-Soares F, Araújo GS, Zamudio R, Sant Anna HP, Santos HC, Duarte NE, Fiaccone RL, Figueiredo CA, Silva TM, Costa GN, Beleza S, Berg DE, Cabrera L, Debortoli G, Duarte D, Ghirotto S, Gilman RH, Gonçalves VF, Marrero AR, Muniz YC, Weissensteiner H, Yeager M, Rodrigues LC, Barreto ML, Lima-Costa MF, Pereira AC, Rodrigues MR, Tarazona-Santos E, Brazilian EPIGEN Project Consortium. Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations. Proc Natl Acad Sci USA. 2015; 112:8696-701. [PMID: 26124090]